Astrazeneca plc (AZN) RNS Announcements

Date	Time	Date	TitleTitle (filtered)	Source
01/09/21	15:00:06	1 Sept 2021	Total Voting Rights	Total Voting Rights	RNS
26/08/21	07:05:00	26 Aug 2021	Forxiga approved in Japan for CKD	Forxiga approved in Japan for CKD	RNS
26/08/21	07:00:02	26 Aug 2021	ALXN1840 Wilson Phase III met primary endpoint	ALXN1840 Wilson Phase III met primary endpoint	RNS
20/08/21	07:05:04	20 Aug 2021	Update on Ultomiris Phase III ALS trial	Update on Ultomiris Phase III ALS trial	RNS
20/08/21	07:00:09	20 Aug 2021	AZD7442 prophylaxis trial met primary endpoint	AZD7442 prophylaxis trial met primary endpoint	RNS
16/08/21	15:00:01	16 Aug 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
11/08/21	14:35:06	11 Aug 2021	Update on US review of roxadustat	Update on US review of roxadustat	RNS
09/08/21	07:05:04	9 Aug 2021	Forxiga approved in the EU for CKD	Forxiga approved in the EU for CKD	RNS
09/08/21	07:00:07	9 Aug 2021	Enhertu head-to-head trial meets primary endpoint	Enhertu head-to-head trial meets primary endpoint	RNS
02/08/21	15:00:07	2 Aug 2021	Total Voting Rights	Total Voting Rights	RNS
02/08/21	07:00:08	2 Aug 2021	Saphnelo approved in the US for SLE	Saphnelo approved in the US for SLE	RNS
29/07/21	07:00:07	29 Jul 2021	AZN: H1 2021 Results	AZN: H1 2021 Results	RNS
26/07/21	07:00:08	26 Jul 2021	Ultomiris recommended in EU for children with PNH	Ultomiris recommended in EU for children with PNH	RNS
22/07/21	07:00:07	22 Jul 2021	Directorate Change	Directorate Change	RNS
21/07/21	15:56:36	21 Jul 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
21/07/21	15:45:05	21 Jul 2021	Total Voting Rights	Total Voting Rights	RNS
21/07/21	13:45:08	21 Jul 2021	Acquisition of Alexion completed	Acquisition of Alexion completed	RNS
19/07/21	07:00:07	19 Jul 2021	Imfinzi approved in China for extensive-stage SCLC	Imfinzi approved in China for extensive-stage SCLC	RNS
16/07/21	07:00:03	16 Jul 2021	Status on US FDA Advisory Committee for roxadustat	Status on US FDA Advisory Committee for roxadustat	RNS
14/07/21	07:08:38	14 Jul 2021	AstraZeneca-Alexion transaction cleared in the UK	AstraZeneca-Alexion transaction cleared in the UK	RNS
08/07/21	07:00:04	8 Jul 2021	Tezepelumab granted FDA Priority Review for asthma	Tezepelumab granted FDA Priority Review for asthma	RNS
06/07/21	07:00:06	6 Jul 2021	AstraZeneca-Alexion transaction cleared in the EU	AstraZeneca-Alexion transaction cleared in the EU	RNS
01/07/21	15:00:01	1 Jul 2021	Total Voting Rights	Total Voting Rights	RNS
28/06/21	07:05:07	28 Jun 2021	Forxiga recommended in EU for patients with CKD	Forxiga recommended in EU for patients with CKD	RNS
28/06/21	07:00:12	28 Jun 2021	Nirsevimab PhII/III trial confirms safety profile	Nirsevimab PhII/III trial confirms safety profile	RNS
24/06/21	07:00:04	24 Jun 2021	Lynparza approved in China for prostate cancer	Lynparza approved in China for prostate cancer	RNS
23/06/21	07:00:05	23 Jun 2021	Orpathys approved in China for lung cancer	Orpathys approved in China for lung cancer	RNS
22/06/21	07:00:06	22 Jun 2021	Koselugo approved in the EU for children with NF1	Koselugo approved in the EU for children with NF1	RNS
15/06/21	07:00:08	15 Jun 2021	Update on AZD7442 STORM CHASER trial	Update on AZD7442 STORM CHASER trial	RNS
07/06/21	07:00:12	7 Jun 2021	Calquence head-to-head results versus ibrutinib	Calquence head-to-head results versus ibrutinib	RNS
04/06/21	07:05:02	4 Jun 2021	Lynparza reduced recurrence risk in breast cancer	Lynparza reduced recurrence risk in breast cancer	RNS
04/06/21	07:00:04	4 Jun 2021	AstraZeneca appoints new Chief Financial Officer	AstraZeneca appoints new Chief Financial Officer	RNS
02/06/21	07:00:04	2 Jun 2021	Publication of Final Terms	Publication of Final Terms	RNS
01/06/21	15:01:02	1 Jun 2021	Block listing Interim Review	Block listing Interim Review	RNS
01/06/21	15:00:01	1 Jun 2021	Total Voting Rights	Total Voting Rights	RNS
28/05/21	07:00:08	28 May 2021	Tagrisso approved in EU in early lung cancer	Tagrisso approved in EU in early lung cancer	RNS
27/05/21	16:41:48	27 May 2021	Second Price Monitoring Extn	Second Price Monitoring Extn	RNS
27/05/21	16:36:15	27 May 2021	Price Monitoring Extension	Price Monitoring Extension	RNS
27/05/21	07:00:08	27 May 2021	AstraZeneca prices a EUR800m bond offering	AstraZeneca prices a EUR800m bond offering	RNS
26/05/21	07:00:08	26 May 2021	AstraZeneca prices a $7bn bond offering	AstraZeneca prices a $7bn bond offering	RNS
25/05/21	07:00:06	25 May 2021	EMTN programme update - publication of Prospectus	EMTN programme update - publication of Prospectus	RNS
21/05/21	07:00:08	21 May 2021	Vaxzevria COVID-19 vaccine approved in Japan	Vaxzevria COVID-19 vaccine approved in Japan	RNS
18/05/21	15:30:04	18 May 2021	Director/PDMR Shareholding	Director/PDMR Shareholding	RNS
11/05/21	14:00:02	11 May 2021	Result of AGM	Result of AGM	RNS
11/05/21	13:55:47	11 May 2021	Shareholders vote in favour of Alexion acquisition	Shareholders vote in favour of Alexion acquisition	RNS
07/05/21	07:00:03	7 May 2021	Imfinzi + tremelimumab showed survival in POSEIDON	Imfinzi + tremelimumab showed survival in POSEIDON	RNS
04/05/21	15:00:05	4 May 2021	Total Voting Rights	Total Voting Rights	RNS
04/05/21	07:00:12	4 May 2021	Farxiga approved in the US for CKD	Farxiga approved in the US for CKD	RNS
30/04/21	07:00:05	30 Apr 2021	AZN: First quarter 2021 results	AZN: First quarter 2021 results	RNS
26/04/21	07:10:07	26 Apr 2021	Selumetinib recommended for EU approval in NF1	Selumetinib recommended for EU approval in NF1	RNS

Showing 501–550 of 1,436 announcements

Astrazeneca plc RNS

Astrazeneca plc RNS